Mesothelioma Research News

Click the links below to view the Mesothelioma Lung Cancer Asbestos news article of your choice.


Combination immunotherapy improves survival in mouse models of mesothelioma

Mon, 02 Apr 2018 14:24:58 EDT

Investigators have found that combined treatment with two cancer immunotherapy drugs -- one a novel immune modulator and one that focuses and activates the anti-tumor immune response -- significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.

Subset of carbon nanotubes poses cancer risk similar to asbestos in mice

Mon, 06 Nov 2017 13:20:18 EST

Researchers have shown for the first time in mice that long and thin nanomaterials called carbon nanotubes may have the same carcinogenic effect as asbestos: they can induce the formation of mesothelioma. The findings were observed in 10 percent -- 25 percent of the 32 animals included in the study, which has not yet been replicated in humans.

Loose-fill asbestos insulation and health

Thu, 02 Nov 2017 09:11:18 EDT

A landmark study into the health impacts of living in a house with loose-fill asbestos insulation.

Rare genetic cause of peritoneal mesothelioma points to targeted therapy

Thu, 14 Sep 2017 15:23:47 EDT

Investigators have uncovered a new genetic cause of mesothelioma: a genetic rearrangement in the ALK gene, observed in three patients with peritoneal mesothelioma. Unlike previously known causes, this new discovery points to a potential therapeutic approach for those few patients whose tumors harbor the mutation.

First immunotherapy for mesothelioma on the horizon, early research suggests

Mon, 05 Jun 2017 11:00:54 EDT

Malignant pleural mesothelioma or MPM is a rare cancer, but its incidence has been rising. This cancer is usually associated with asbestos exposure, and patients have a median life expectancy of only 13-15 months. All patients relapse despite initial chemotherapy, more than 50% of them within six months after stopping treatment. There are currently no effective therapeutic options for patients with MPM.

Medical News Today

Pneumoconiosis: The risk of breathing in dust

Sun, 08 Oct 2017 09:00:00 PDT

Pneumoconiosis is a lung disease caused by dust particles. Symptoms include breathing difficulty and a cough. It can result from exposure to coal dust, asbestos particles, and cotton dust. It is considered an occupational risk. Complications include tuberculosis and respiratory failure. Employers may provide screening.

Rare genetic cause of peritoneal mesothelioma points to targeted therapy

Fri, 15 Sep 2017 06:00:00 PDT

Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos.

Mesothelioma shows promising response to existing immunotherapy drug

Fri, 31 Mar 2017 07:00:00 PDT

Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.

Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma

Tue, 25 Oct 2016 00:00:00 PDT

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

Go to main Mesothelioma cancer resource page...